Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials

Triple-negative breast cancer (TNBC) is an aggressive malignancy with a poor prognosis despite the high rates of response to chemotherapy. This scenario highlights the need to develop novel therapies and/or treatment strategies to reduce the mortality associated with TNBC. The neoadjuvant setting pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Amos, Keith D., Adamo, Barbara, Anders, Carey K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270519/
https://www.ncbi.nlm.nih.gov/pubmed/22461984
http://dx.doi.org/10.1155/2012/385978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270519/
https://www.ncbi.nlm.nih.gov/pubmed/22461984
http://dx.doi.org/10.1155/2012/385978

Ejemplares similares